메뉴 건너뛰기




Volumn 18, Issue 1, 2012, Pages 1-3

Perspectives for the treatment of anemia in heart failure: Is there a role for vasopressin antagonists?

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ERYTHROPOIETIN; HEMOGLOBIN; IOTALAMIC ACID I 125; IRON; TOLVAPTAN;

EID: 84856247556     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00233.x     Document Type: Note
Times cited : (2)

References (39)
  • 1
    • 79251621430 scopus 로고    scopus 로고
    • Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia
    • Noumi B, Teruya S, Salomon S, et al. Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia. Congest Heart Fail. 2011;17:14-18.
    • (2011) Congest Heart Fail , vol.17 , pp. 14-18
    • Noumi, B.1    Teruya, S.2    Salomon, S.3
  • 2
    • 33748907013 scopus 로고    scopus 로고
    • Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients
    • Colin-Ramirez E, Castillo-Martinez L, Orea-Tejeda A, et al. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients. Clin Nutr. 2006;25:746-757.
    • (2006) Clin Nutr , vol.25 , pp. 746-757
    • Colin-Ramirez, E.1    Castillo-Martinez, L.2    Orea-Tejeda, A.3
  • 4
    • 0034128813 scopus 로고    scopus 로고
    • The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
    • Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 1737-1744
    • Silverberg, D.S.1    Wexler, D.2    Blum, M.3
  • 5
    • 0037024202 scopus 로고    scopus 로고
    • Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure
    • Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-1786.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1780-1786
    • Horwich, T.B.1    Fonarow, G.C.2    Hamilton, M.A.3
  • 6
    • 0037458095 scopus 로고    scopus 로고
    • Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure
    • Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation. 2003;107:223-225.
    • (2003) Circulation , vol.107 , pp. 223-225
    • Ezekowitz, J.A.1    McAlister, F.A.2    Armstrong, P.W.3
  • 7
    • 0043011312 scopus 로고    scopus 로고
    • Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure
    • Felker GM, Gattis WA, Leimberger JD, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol. 2003;92:625-628.
    • (2003) Am J Cardiol , vol.92 , pp. 625-628
    • Felker, G.M.1    Gattis, W.A.2    Leimberger, J.D.3
  • 8
    • 43749089210 scopus 로고    scopus 로고
    • Anemia and chronic heart failure implications and treatment options
    • Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol. 2008;52:501-511.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 501-511
    • Anand, I.S.1
  • 9
    • 24044458237 scopus 로고    scopus 로고
    • Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT
    • Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation. 2005;112:1121-1127.
    • (2005) Circulation , vol.112 , pp. 1121-1127
    • Anand, I.S.1    Kuskowski, M.A.2    Rector, T.S.3
  • 10
    • 0034427129 scopus 로고    scopus 로고
    • Pharmacotherapy in congestive heart failure: ACE inhibitors and anemia in congestive heart failure
    • Sica DS. Pharmacotherapy in congestive heart failure: ACE inhibitors and anemia in congestive heart failure. Congest Heart Fail. 2000;6:330-332.
    • (2000) Congest Heart Fail , vol.6 , pp. 330-332
    • Sica, D.S.1
  • 11
    • 1842702872 scopus 로고    scopus 로고
    • The pathophysiological basis of anaemia in chronic heart failure
    • Coats AJS. The pathophysiological basis of anaemia in chronic heart failure. Eur J Heart Fail. 2003;2:213-216.
    • (2003) Eur J Heart Fail , vol.2 , pp. 213-216
    • Coats, A.J.S.1
  • 12
    • 0037458102 scopus 로고    scopus 로고
    • Hemodilution is common in patients with advanced heart failure
    • Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-229.
    • (2003) Circulation , vol.107 , pp. 226-229
    • Androne, A.S.1    Katz, S.D.2    Lund, L.3
  • 13
    • 3042730052 scopus 로고    scopus 로고
    • Are hematinic deficiencies the cause of anemia in chronic heart failure?
    • Witte KK, Desilva R, Chattopadhyay S, et al. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J. 2004;147:924-930.
    • (2004) Am Heart J , vol.147 , pp. 924-930
    • Witte, K.K.1    Desilva, R.2    Chattopadhyay, S.3
  • 15
    • 33746526038 scopus 로고    scopus 로고
    • Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
    • Silverberg DS, Wexler D, Iaina A, et al. Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006;38:295-310.
    • (2006) Int Urol Nephrol , vol.38 , pp. 295-310
    • Silverberg, D.S.1    Wexler, D.2    Iaina, A.3
  • 16
    • 0035370037 scopus 로고    scopus 로고
    • The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
    • Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775-1780.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1775-1780
    • Silverberg, D.S.1    Wexler, D.2    Sheps, D.3
  • 17
    • 0037458127 scopus 로고    scopus 로고
    • Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure
    • Mancini DM, Katz SD, Lang CC, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-299.
    • (2003) Circulation , vol.107 , pp. 294-299
    • Mancini, D.M.1    Katz, S.D.2    Lang, C.C.3
  • 18
    • 33846936320 scopus 로고    scopus 로고
    • Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial
    • Ponikowski P, Anker SD, Szachniewicz J, et al. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2007;49:753-762.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 753-762
    • Ponikowski, P.1    Anker, S.D.2    Szachniewicz, J.3
  • 19
    • 34548798205 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
    • van Veldhuisen DJ, Dickstein K, Cohen-Solal A, et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J. 2007;28:2208-2216.
    • (2007) Eur Heart J , vol.28 , pp. 2208-2216
    • van Veldhuisen, D.J.1    Dickstein, K.2    Cohen-Solal, A.3
  • 20
    • 41049115024 scopus 로고    scopus 로고
    • Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia
    • Ghali JK, Anand IS, Abraham WT, et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation. 2008;117:526-535.
    • (2008) Circulation , vol.117 , pp. 526-535
    • Ghali, J.K.1    Anand, I.S.2    Abraham, W.T.3
  • 21
    • 0028124805 scopus 로고
    • Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles
    • Volpe M, Tritto C, Testa U, et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 1994;74:468-473.
    • (1994) Am J Cardiol , vol.74 , pp. 468-473
    • Volpe, M.1    Tritto, C.2    Testa, U.3
  • 22
    • 3242799671 scopus 로고    scopus 로고
    • Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure
    • van der Meer P, Voors AA, Lipsic E, et al. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol. 2004;44:63-67.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 63-67
    • van der Meer, P.1    Voors, A.A.2    Lipsic, E.3
  • 23
    • 53249107656 scopus 로고    scopus 로고
    • Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume
    • Adlbrecht C, Kommata S, Hulsmann M, et al. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J. 2008;29:2343-2350.
    • (2008) Eur Heart J , vol.29 , pp. 2343-2350
    • Adlbrecht, C.1    Kommata, S.2    Hulsmann, M.3
  • 24
    • 33847053226 scopus 로고    scopus 로고
    • Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well
    • Westenbrink BD, Visser FW, Voors AA, et al. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J. 2007;28:166-171.
    • (2007) Eur Heart J , vol.28 , pp. 166-171
    • Westenbrink, B.D.1    Visser, F.W.2    Voors, A.A.3
  • 25
    • 0024497513 scopus 로고
    • The limited reliability of physical signs for estimating hemodynamics in chronic heart failure
    • Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-888.
    • (1989) JAMA , vol.261 , pp. 884-888
    • Stevenson, L.W.1    Perloff, J.K.2
  • 26
    • 17444382670 scopus 로고    scopus 로고
    • Neurohormonal activation in congestive heart failure and the role of vasopressin
    • Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol. 2005;95:8B-13B.
    • (2005) Am J Cardiol , vol.95
    • Chatterjee, K.1
  • 27
    • 0030357987 scopus 로고    scopus 로고
    • In human patients, vascular water retention during DDAVP-related hyponatremia occurs mainly in the plasma volume and not in the erythrocyte
    • Namias B, Soupart A, Kornreich A, Decaux G. In human patients, vascular water retention during DDAVP-related hyponatremia occurs mainly in the plasma volume and not in the erythrocyte. J Lab Clin Med. 1996;128:612-617.
    • (1996) J Lab Clin Med , vol.128 , pp. 612-617
    • Namias, B.1    Soupart, A.2    Kornreich, A.3    Decaux, G.4
  • 28
    • 0022039257 scopus 로고
    • Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure
    • Uretsky BF, Verbalis JG, Generalovich T, et al. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Am J Physiol. 1985;248:H396-H402.
    • (1985) Am J Physiol , vol.248
    • Uretsky, B.F.1    Verbalis, J.G.2    Generalovich, T.3
  • 29
    • 0029902696 scopus 로고    scopus 로고
    • Vasopressin receptors in health and disease
    • Bichet DG. Vasopressin receptors in health and disease. Kidney Int. 1996;49:1706-1711.
    • (1996) Kidney Int , vol.49 , pp. 1706-1711
    • Bichet, D.G.1
  • 30
    • 0019861237 scopus 로고
    • Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure
    • Szatalowicz VL, Arnold PE, Chaimovitz C, et al. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981;305:263-266.
    • (1981) N Engl J Med , vol.305 , pp. 263-266
    • Szatalowicz, V.L.1    Arnold, P.E.2    Chaimovitz, C.3
  • 31
    • 0020617013 scopus 로고
    • Increased plasma arginine vasopressin levels in patients with congestive heart failure
    • Goldsmith SR, Francis GS, Cowley AW Jr, et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983;1:1385-1390.
    • (1983) J Am Coll Cardiol , vol.1 , pp. 1385-1390
    • Goldsmith, S.R.1    Francis, G.S.2    Cowley Jr., A.W.3
  • 32
    • 0025153828 scopus 로고
    • Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
    • Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
    • (1990) Circulation , vol.82 , pp. 1724-1729
    • Francis, G.S.1    Benedict, C.2    Johnstone, D.E.3
  • 33
    • 28444435896 scopus 로고    scopus 로고
    • Possible vascular role of increased plasma arginine vasopressin in congestive heart failure
    • Nakamura T, Funayama H, Yoshimura A, et al. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Int J Cardiol. 2006;106:191-195.
    • (2006) Int J Cardiol , vol.106 , pp. 191-195
    • Nakamura, T.1    Funayama, H.2    Yoshimura, A.3
  • 34
    • 27644562291 scopus 로고    scopus 로고
    • Vasopressin antagonism in heart failure
    • Goldsmith SR, Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol. 2005;46:1785-1791.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1785-1791
    • Goldsmith, S.R.1    Gheorghiade, M.2
  • 35
    • 0033584460 scopus 로고    scopus 로고
    • Hormones and hemodynamics in heart failure
    • Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
    • (1999) N Engl J Med , vol.341 , pp. 577-585
    • Schrier, R.W.1    Abraham, W.T.2
  • 36
    • 46849109301 scopus 로고    scopus 로고
    • Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
    • Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol. 2008;52:266-272.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 266-272
    • Neuhold, S.1    Huelsmann, M.2    Strunk, G.3
  • 37
    • 77953839299 scopus 로고    scopus 로고
    • Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan
    • Miyazaki T, Ohmoto K, Hirose T, Fujiki H. Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan. J Endocrinol. 2010;206:105-111.
    • (2010) J Endocrinol , vol.206 , pp. 105-111
    • Miyazaki, T.1    Ohmoto, K.2    Hirose, T.3    Fujiki, H.4
  • 38
    • 49149119580 scopus 로고    scopus 로고
    • Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia
    • Finley JJ, Konstam MA, Udelson JE. Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia. Circulation. 2008;118:410-421.
    • (2008) Circulation , vol.118 , pp. 410-421
    • Finley, J.J.1    Konstam, M.A.2    Udelson, J.E.3
  • 39
    • 0025176687 scopus 로고
    • Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction
    • Mulinari RA, Gavras I, Wang YX, et al. Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction. Circulation. 1990;81:308-311.
    • (1990) Circulation , vol.81 , pp. 308-311
    • Mulinari, R.A.1    Gavras, I.2    Wang, Y.X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.